跳至主要内容
临床试验/NCT05998109
NCT05998109已完成不适用

PheCheck Feasibility Study

Lumos Diagnostics1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年12月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Concentration of phenylalanine (Phe) from PheCheck as compared to HPLC amino acid analyzer

研究概览

简要总结

The goal of this feasibility study clinical trial is to compare the accuracy of PheCheck™ for the rapid quantitative detection of phenylalanine (Phe) with the gold standard (HPLC amino acid analyzer), in patients with PKU.

The main aims are:

  • Evaluate the accuracy of PheCheck as compared to the gold standard
  • Evaluate ease of use by lay participants

详细描述

The primary objective of this feasibility study is to evaluate the accuracy of the analyte concentration of PheCheck™ for the rapid, quantitative detection of phenylalanine (Phe) from capillary blood compared to the gold standard (HPLC amino acid analyzer) which quantitatively measures Phe in venous blood.

The study will enroll subjects into one study cohort. It will include patients 10 years or older, monitored for Phenylketonuria (PKU), hyperphenylalaninemia or PKU during pregnancy.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
10 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 10 years of age or older
  • Being monitored for Phenylketonuria (PKU), hyperphenylalaninemia or for PKU during pregnancy Signed informed consent

排除标准

  • Younger than 10 years of age
  • Not being monitored for Phenylketonuria (PKU), hyperphenylalaninemia or for PKU during pregnancy
  • Lack of signed informed consent
  • Previous enrollment in the study and has completed study visit 1 and 2

结局指标

主要结局

Concentration of phenylalanine (Phe) from PheCheck as compared to HPLC amino acid analyzer

时间窗: 6-8 weeks

The primary outcome is the concentration of phenylalanine (Phe) from capillary blood as compared to the gold standard HPLC amino acid analyzer

次要结局

未报告次要终点

研究者

发起方
Lumos Diagnostics
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验